Chief Technology Officer, NoNO Inc.
Phase III Results for Nerinetide
Dr. Garman joined NoNO Inc in 2010 after 12 years in biotechnology business development to expand the company’s capabilities in preclinical development, clinical development, and manufacturing. Dr. Garman has over 30 years of experience in laboratory science and has spent the past 18 years in biotechnology, holding various positions encompassing finance, quality assurance, manufacturing, intellectual property, and business development. The last 13 years of this extensive background have been focused on the development of neurotherapeutics. Dr. Garman received his Ph.D. in Developmental Biology from Stanford University.